Testing effectiveness (Phase 2)Study completedNCT05266729
What this trial is testing
Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area
Who this might be right for
Moderate or Severe Submental Fullness
AMIpharm Co., Ltd. 96